These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis. Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196 [TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis. Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661 [TBL] [Abstract][Full Text] [Related]
7. Platelet count combined with right liver volume and spleen volume measured by magnetic resonance imaging for identifying cirrhosis and esophageal varices. Chen XL; Chen TW; Zhang XM; Li ZL; Zeng NL; Zhou P; Li H; Ren J; Xu GH; Hu JN World J Gastroenterol; 2015 Sep; 21(35):10184-91. PubMed ID: 26401083 [TBL] [Abstract][Full Text] [Related]
8. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Lisotti A; Azzaroli F; Buonfiglioli F; Montagnani M; Cecinato P; Turco L; Calvanese C; Simoni P; Guardigli M; Arena R; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G Hepatology; 2014 Feb; 59(2):643-50. PubMed ID: 24038116 [TBL] [Abstract][Full Text] [Related]
9. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea]. Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762 [TBL] [Abstract][Full Text] [Related]
10. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial. Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333 [TBL] [Abstract][Full Text] [Related]
11. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Vizzutti F; Arena U; Romanelli RG; Rega L; Foschi M; Colagrande S; Petrarca A; Moscarella S; Belli G; Zignego AL; Marra F; Laffi G; Pinzani M Hepatology; 2007 May; 45(5):1290-7. PubMed ID: 17464971 [TBL] [Abstract][Full Text] [Related]
12. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient]. Jiang FR; Yan HD Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395 [No Abstract] [Full Text] [Related]
13. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension. Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126 [TBL] [Abstract][Full Text] [Related]
14. Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis. Bellis L; Nicodemo S; Galossi A; Guarisco R; Spilabotti L; Durola L; Dell'Unto O; Puoti C J Gastrointestin Liver Dis; 2007 Sep; 16(3):273-7. PubMed ID: 17925921 [TBL] [Abstract][Full Text] [Related]
15. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. Colecchia A; Colli A; Casazza G; Mandolesi D; Schiumerini R; Reggiani LB; Marasco G; Taddia M; Lisotti A; Mazzella G; Di Biase AR; Golfieri R; Pinzani M; Festi D J Hepatol; 2014 Jun; 60(6):1158-64. PubMed ID: 24607624 [TBL] [Abstract][Full Text] [Related]
16. Varices on computed tomography are surrogate of clinically significant portal hypertension and can predict survival in compensated cirrhosis patients. Lee DH; Ahn JH; Chung JW; Kim YJ; Cha SW; Kim MY; Baik SK J Gastroenterol Hepatol; 2019 Feb; 34(2):450-457. PubMed ID: 29900587 [TBL] [Abstract][Full Text] [Related]
17. Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis. Montes Ramirez ML; Pascual-Pareja JF; Sánchez-Conde M; Bernardino De la Serna JI; Zamora Vargas FX; Miralles P; Castro JM; Ramírez M; Gutierrez I; Gonzalez-García J; Berenguer J; Arribas López JR AIDS; 2012 Sep; 26(14):1807-12. PubMed ID: 22781218 [TBL] [Abstract][Full Text] [Related]
18. Utilization of platelet count spleen diameter ratio in predicting the presence of esophageal varices in patients with cirrhosis. Schwarzenberger E; Meyer T; Golla V; Sahdala NP; Min AD J Clin Gastroenterol; 2010 Feb; 44(2):146-50. PubMed ID: 19593164 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of gastroesophageal varices and portal collateral venous abnormalities by endosonography in cirrhotic patients. Lee YT; Chan FK; Ching JY; Lai CW; Leung VK; Chung SC; Sung JJ Endoscopy; 2002 May; 34(5):391-8. PubMed ID: 11972271 [TBL] [Abstract][Full Text] [Related]
20. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial. Pollo-Flores P; Soldan M; Santos UC; Kunz DG; Mattos DE; da Silva AC; Marchiori RC; Rezende GF Dig Liver Dis; 2015 Nov; 47(11):957-63. PubMed ID: 26321186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]